Related Experiment Video
Updated: Apr 8, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Beyond vascular inflammation--recent advances in understanding atherosclerosis
Dennis Wolf1, Andreas Zirlik2, Klaus Ley3
1Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle Drive, La Jolla, CA, 92037, USA.
Atherosclerosis, a leading cause of death, is now understood as a chronic inflammatory disease. Research into vascular immunology and autoimmune responses offers potential for new therapeutic vaccines against atherosclerosis.
Area of Science:
- Cardiovascular Research
- Immunology
- Vascular Biology
Background:
- Atherosclerosis is a major global health threat, with rising rates of stroke and myocardial infarction.
- Initially viewed as a lipid disorder, it's now recognized as a chronic inflammatory condition.
- The role of autoimmune processes and specific immune cells in atherosclerosis is increasingly evident.
Purpose of the Study:
- To explore the role of inflammation and autoimmunity in atherosclerosis.
- To investigate the cellular mechanisms underlying atherosclerotic plaque development.
- To identify potential targets for novel immunomodulatory therapies.
Main Methods:
- Utilizing mouse models of atherosclerosis.
- Employing flow cytometry to analyze cellular infiltrates.
- Applying multiphoton microscopy for in vivo visualization of immune cell interactions.
Main Results:
- Distinct inflammatory cells have been identified as key players in triggering or inhibiting atherosclerotic plaque progression.
- Direct visualization of T cell and antigen-presenting cell interactions within the vessel wall has been achieved.
- Evidence supports both protective and damaging autoimmune responses in vascular immunology.
Conclusions:
- Vascular immunology is an emerging field with significant therapeutic potential for cardiovascular diseases.
- Targeting inflammation and autoimmunity offers promising avenues for prevention and treatment.
- Development of antigen-specific immunomodulatory strategies, including vaccines, is a future direction.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

